Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarelix in Men With Biochemically Recurrent Castration Sensitive Prostate Cancer After Radical Prostatectomy
Clinical trial NCT02020070 · COMPLETED
Trial details
- NCT number
- NCT02020070
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-18
- Primary completion
- 2026-06-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.